ChatDocto
Find a doctor
White scored tablet

OLANZIA ORO 20 mg

Olanzapine · orodispersible tablets

B/30Oral use
120,240 DTRecorded public price · B/30
See all pack prices
Strength20 mg
Therapeutic classSYSTEME NERVEUX
ATC codeN05AH03

About this medicine

OLANZIA ORO 20 mg orodispersible tablets is listed in Tunisia's medicine catalog under the active ingredient Olanzapine. This page brings together its recorded pack formats, prices and CNAM coverage information.

What is this medicine used for?

Review pending

A reviewed explanation of uses is not yet published for this medicine in this language. Ask a pharmacist for the leaflet for your exact product.

What side effects should I know about?

Review pending

A reviewed side-effect guide is not yet published for this medicine in this language. This does not mean that the medicine has no side effects. Read your product leaflet or ask a pharmacist.

Price by pack

Compare the recorded price for each exact pack. A catalog entry does not confirm pharmacy stock.

  • Pack · B/30

    30 units in this pack

    Recorded public price120,240 DT
    AMM No.
    9413032
    CNAM code
    303017
    CNAM reference amount
    120,240 DT

    Price source: CNAM — Liste des médicaments remboursables · 2026-08-04

    Source recorded: August 23, 2026

    Price effective date not provided

This reference amount is not a guaranteed refund or a personal out-of-pocket estimate. Your coverage conditions must be confirmed separately.

Medicine details

Dosage formorodispersible tablets
Route of administrationOral use
LaboratoryADVANS PHARMA
OriginGeneric
ScheduleA
ATC codeN05AH03 — Olanzapine
Therapeutic classSYSTEME NERVEUX
Prior authorization

Medicines with matching catalog characteristics

These entries match the recorded ingredient, strength, form and route. This does not establish that they can replace your medicine; confirm any change with a pharmacist.

OROZA 20 20 mgComprimés orodispersiblesPHARMACARE · B/10
Recorded public price99,240 DT

Price source: CNAM — Liste des médicaments remboursables · 2026-08-04

Source recorded: August 23, 2026